ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.790
+0.130 (7.83%)
At close: Jan 21, 2025, 4:00 PM
1.700
-0.090 (-5.03%)
After-hours: Jan 21, 2025, 4:38 PM EST
ProKidney Employees
ProKidney had 163 employees as of December 31, 2023. The number of employees increased by 76 or 87.36% compared to the previous year.
Employees
163
Change (1Y)
76
Growth (1Y)
87.36%
Revenue / Employee
n/a
Profits / Employee
-$279,810
Market Cap
522.07M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 163 | 76 | 87.36% |
Dec 31, 2022 | 87 | 28 | 47.46% |
Dec 31, 2021 | 59 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PROK News
- 2 months ago - ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting - GlobeNewsWire
- 2 months ago - ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024 - GlobeNewsWire
- 3 months ago - ProKidney to Participate in the UBS Virtual Organ Restoration Day - GlobeNewsWire
- 5 months ago - ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S. - GlobeNewsWire
- 5 months ago - ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 5 months ago - ProKidney Reports Business Updates and Second Quarter 2024 Financial Results - GlobeNewsWire